Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: A randomised, double-blind, placebo-controlled, phase 3 study - Weber, M A; Mansfield, T A; Cain, V A; Iqbal, N; Parikh, S; Ptaszynska, A (Lancet Diabetes Endocrinol, 2016)